Actively Recruiting
Study on Blood Pressure Variability and Frailty in Older Adults with Hypertension: the HypoPHrail Study
Led by Istituto Auxologico Italiano · Updated on 2026-03-30
220
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to study blood pressure variability and frailty in older adults who have hypertension. It focuses on whether a hypotensive phenotype, defined by specific low daytime systolic blood pressure episodes detected through ambulatory blood pressure monitoring, is linked to adverse events such as death, hospitalization, falls, uncontrolled hypertension emergencies, or major cardiovascular events. This observational, prospective, single-center study is conducted by Istituto Auxologico Italiano and is non-profit in nature. Participants are assessed using diagnostic tests and questionnaires that measure office blood pressure, orthostatic hypotension, 24-hour ambulatory blood pressure, and frailty using several assessment tools. The study also examines the relationship between home blood pressure variability and frailty, as well as short-term blood pressure variability and adverse events. The prevalence of the hypotensive phenotype in hypertensive individuals according to frailty status is also determined. During the study, participants will undergo blood pressure monitoring and frailty assessments. Researchers will track the incidence of adverse events over a 24-month follow-up period and assess the prevalence of the hypotensive phenotype at the start of the study. The total participation duration includes baseline assessments and follow-up to observe outcomes related to blood pressure variability and frailty in older adults with hypertension.
CONDITIONS
Brief Title
Study on Blood Pressure Variability and Frailty in the Older People
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 75 years
- Diagnosis of hypertension according to European Society of Cardiology guidelines
- Consent of the patient or legal representative to participate in the study
You will not qualify if you...
- Refusal to participate by the patient or legal representative
- Life expectancy less than 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline
Participants undergo diagnostic tests including assessment of office blood pressure, orthostatic hypotension, 24-hour ambulatory blood pressure monitoring, and frailty assessment using questionnaires.
1 visit (in-person)
Duration - Up to 24 months
Participants are monitored for adverse events such as hospitalization, falls, and cardiovascular events over the follow-up period.
Periodic follow-up visits for up to 24 months
Trial Site Locations
Total: 1 location
1
Istituto Auxologico Italiano IRCCS
Milan, Italy, 20145
Actively Recruiting
Research Team
A
Alessandro Croce, MD
L
Luca Grappiolo, Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here